|
Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"
RECRUITINGSponsored by Fundación Sociedad Española de Oncologia Médica
Actively Recruiting
SponsorFundación Sociedad Española de Oncologia Médica
Started2018-07-04
Est. completion2026-07
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT03855592
Summary
Epidemiological, observational, non-interventional, multicentric study on patients diagnosed with cancer who develop a venous or arterial thromboembolic episode, symptomatic or incidental, within a month prior to cancer diagnosis or at anytime after such diagnosis
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Over 18 years of age with a histologically confirmed diagnosis of malignant tumor. * Venous or arterial thromboembolism episode, symptomatic or incidental, in the month prior or any time after the cancer diagnosis and in the three previous months to enrollment, confirmed with an imaging technique: Doppler echocardiography, computed tomography (CT) angiography, etc. * Signing of informed consent. Exclusion Criteria: * Clinical diagnosis of thromboembolic event without radiological confirmation. * Presenting a single episode of superficial thrombophlebitis without association with another thromboembolic event. * Each patient will be recorded just once, and therefore a second thromboembolic event will be considered a rethrombosis and will be recorded as such. Patients with a rethrombosis and a previous thromboembolic event before the start of the study in each center will not be able to be included.
Conditions2
CancerThromboembolism
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorFundación Sociedad Española de Oncologia Médica
Started2018-07-04
Est. completion2026-07
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT03855592